get a key
steadybase-$ company AIFF
account_id none on file
legal_name Firefly Neuroscience, Inc.
ticker AIFF
cik 803578
domain fireflyneuro.com
entry_point_account_id none on file
name Firefly Neuroscience Inc.
exchange Nasdaq
sector Technology
hq Kenmore, NY, United States
calls 0 filings 4 executives 7 family 0
why_nownone on file
callsnone on file
filings
“Board”) of Firefly Neuroscience, Inc., a Delaware corporation (the “Company”), terminated Paul Krzywicki as Chief Financial Officer of the Company, effective September 24, 2026.

filing / Sep 14, 2026 / receipt

Management's plan to address the conditions giving rise to substantial doubt includes: (i) disciplined operating expense management and integration synergies from the Evoke acquisition; (ii) targeted commercial expansion to drive recurring revenue from the combined Evoke and BNA product portfolio; and (iii) continued access to capital markets through equity financings, including our at-the-market offering program wit

filing / Aug 11, 2026 / receipt

Krzywicki, CPA, CGA has served as Firefly’s Chief Financial Officer since March 2024. Mr. Krzywicki initially joined Firefly as its Controller in November 2023 before his appointment as our Chief Financial Officer in March 2024.

filing / Jul 9, 2026 / receipt

It reduces the volume of duplicate information received at your household and helps to reduce our expenses. The SEC rules apply to our Annual Reports on Form 10-K, proxy statements and information statements.

filing / Jul 9, 2026 / receipt

executives
Arun Menawat Chairman - receipt
David DeCaprio President and Chief Operating Officer - receipt
Greg Lipschitz Chief Executive Officer - receipt
Mark T. Krial director - receipt
Paul Krzywicki Chief Financial Officer linkedin receipt
Timothy G. Hannon Chief Financial Officer - receipt
William Pickle director - receipt
familynone on file
upcoming
2026-11-11 earnings call scheduled ir
changes
2025-04-24 President and Chief Operating Officer, appointed sec_8k
2025-04-01 Chief Executive Officer, appointed sec_8k
2025-03-12 Chairman, appointed sec_8k
2025-03-12 Executive Chairman, departed sec_8k
2025-01-06 Interim Chief Executive Officer, appointed sec_8k
2024-12-23 Chief Medical Officer, departed sec_8k
2024-12-03 Executive Chairman, appointed sec_8k
2024-12-03 Executive Chairman, departed sec_8k
2021-10-04 Chief Financial Officer, appointed sec_8k
2021-10-04 Chief Financial Officer, departed sec_8k
2021-08-30 Chief Executive Officer, departed sec_8k
2016-04-05 director, appointed sec_8k
mcp_package_hint
steadybase-$